Product Liability

  • November 14, 2025

    Google, TikTok, Meta Fight Calif. Law Over Kids' Online Feeds

    TikTok, Meta and Google filed separate suits against California Attorney General Rob Bonta in federal court on Thursday seeking to block the state from enforcing a new law's requirement for parental consent before online platforms can deliver personalized content feeds to children, saying the provision infringes on their First Amendment rights.

  • November 14, 2025

    Junior Hockey Players Fight Wage Case Dismissal In Appeal

    Junior hockey players have asked the Ninth Circuit to reverse a lower court toss of their wage suppression suit against the National Hockey League and Canadian leagues, arguing that the territorial reach of U.S. antitrust laws gives United States federal courts jurisdiction.

  • November 14, 2025

    La., Parishes Push To Keep Coastal Suits In State Court

    Louisiana and a pair of its coastal parishes have told the U.S. Supreme Court that the Fifth Circuit correctly concluded that their pollution lawsuits against Chevron and Exxon stemming from their World War II-era oil production belong in state court.

  • November 14, 2025

    Customer PFAS Cases Against Conn. Water Cos. Can Proceed

    Connecticut's utility and public health regulators do not have the authority to grant the relief that customers are seeking through two proposed class actions alleging The Connecticut Water Co. and Aquarion Water Co. sold water contaminated with "forever chemicals," a state court judge ruled in declining to dismiss each case.

  • November 14, 2025

    Camp Lejeune Plaintiffs Say Feds' Overlong Briefs Risk Delays

    Attorneys representing Camp Lejeune toxic water litigants are urging a North Carolina federal court to expedite the upcoming set of bellwether cases, saying the government shouldn't be allowed to cause delay through unnecessary and excessive briefs that together are longer than "Moby Dick."

  • November 14, 2025

    DC Circ. Wary Of DEA Delays In Religious Ayahuasca Case

    A D.C. Circuit panel on Friday appeared skeptical that the Drug Enforcement Administration was justified in its delays processing an Iowa church's application for a religious exemption to the Controlled Substances Act to use a psychedelic in its rites.

  • November 14, 2025

    ByHeart Sued Over Baby Food Botulism Contamination

    A proposed class of consumers is suing ByHeart Inc., alleging that the company failed to warn buyers that its baby formula is contaminated with Clostridium botulinum, which can cause rare but potentially fatal infant botulism.

  • November 14, 2025

    Ex-CFPB Atty Joins Duane Morris' DC Trial Practice

    Duane Morris LLP has hired a senior litigation counsel from the Consumer Financial Protection Bureau who for more than three years in the agency's enforcement division litigated matters related to mortgage fraud, small-dollar lending and a range of related matters.

  • November 14, 2025

    Purdue's $7.4B Ch. 11 Plan To Be Confirmed

    A New York bankruptcy judge agreed to confirm the $7.4 billion Chapter 11 plan of Purdue Pharma LP on Friday, saying he would issue a formal bench ruling next Tuesday explaining his decision.

  • November 13, 2025

    J&J Bellwether Trial Over Talc Cancer Risks Kicks Off In LA

    An attorney for one of two women who claim Johnson & Johnson's talcum products caused their ovarian cancer told a Los Angeles jury Thursday during opening statements in a bellwether trial that decades-old internal documents prove J&J knew its talc products contained toxic levels of asbestos but hid that information.

  • November 13, 2025

    Cancer Patient Was Severely Addicted, Tobacco Jury Told

    The youngest daughter of a longtime smoker who died of lung cancer testified Thursday at trial against Philip Morris and R.J. Reynolds that her mother went to emotional and behavioral extremes to get her "fix."

  • November 13, 2025

    Pipe Maker Names 2nd Firm In Asbestos RICO Suit

    A Los Angeles pipe manufacturer has added Massachusetts-based Sokolove Law to its civil racketeering lawsuit in Illinois federal court accusing Simmons Hanly Conroy LLP and others of orchestrating a scheme to fill the law firms' coffers by bringing baseless asbestos claims, alleging the Sokolove firm acted to find the cases.

  • November 13, 2025

    2nd Circ. Upholds NY's Ban On Selling Diet Pills To Minors

    The Second Circuit on Thursday rejected a trade group's bid to block a New York law that bars companies from selling weight loss and muscle-building supplements to minors, finding the group likely won't win its First Amendment challenges and retailers' "speculative predictions" of lost sales aren't enough to show irreparable harm.

  • November 13, 2025

    Fla. Hospitals Didn't Prove Opioid Conspiracy, Jurors Told

    Walgreens told a state court jury on Thursday that Florida hospitals haven't proven that the company conspired with Walmart, CVS and pharmaceutical manufacturers to illegally dispense opioids through their pharmacies, arguing that the corporations shouldn't be liable for $1.5 billion in damages for contributing to an epidemic of opioid-addicted patients. 

  • November 13, 2025

    Hemp Policy At Crossroads After Government Reopening Bill

    Hemp industry advocates are pledging to use the one-year gap between enactment and implementation of the government funding agreement, which effectively recriminalized most hemp-derived THC products, to craft new regulatory legislation that stops short of a full ban.

  • November 13, 2025

    CVS Reaches Deal In 'Non-Drowsy' Labeling Class Action

    A woman has agreed to settle her proposed class action against CVS Pharmacy accusing it of deceptively marketing its flu medicine as "non-drowsy" when it contained a drug known to cause drowsiness.

  • November 13, 2025

    Weight-Loss Drug MDL In Pa. Grows With 3 New Jersey Cases

    Three New Jersey cases were grouped into multidistrict litigation accusing Eli Lilly & Co. and Novo Nordisk of downplaying alleged side effects of weight loss drugs like Ozempic and Trulicity, according to a transfer order filed in Pennsylvania federal court.

  • November 13, 2025

    Tribe Scores Early Win Against Michigan Fruit Processor

    A Michigan federal judge has ruled that a fruit-processing company illegally discharged millions of gallons of untreated wastewater into wetlands that feed Michigan's Grand Traverse Bay, granting an early win to a Native American tribe and two local environmental nonprofit groups.

  • November 13, 2025

    Injured Riders Ask Justices To Block NJ Transit's Immunity

    Three injured riders from Pennsylvania and New York asked the U.S. Supreme Court to reject New Jersey Transit's bid to escape two negligence suits on interstate sovereign immunity grounds, arguing that the transit agency is legally distinct from the State of New Jersey and should not be insulated from being sued in courts outside the state.

  • November 13, 2025

    NY Judge Declines Sanctions For Citation Errors — Again

    For the second time in as many months, a Manhattan federal judge has stopped short of sanctioning an attorney for including false case citations in a filing, warning the lawyer in an order that he had better not allow errors again.

  • November 13, 2025

    Tesla Fatal Crash Trial Delayed Over Discovery Disputes

    A Florida state judge granted a request Thursday to push back the trial date of a suit against Tesla over a fatal crash and said he would be appointing a magistrate judge to handle the discovery disputes delaying the case.

  • November 12, 2025

    Valsartan Cancer Expert Blocked, Ending First Injury Trial

    What was set to be the first bellwether case in the sprawling multidistrict litigation over contaminated blood pressure medication Valsartan was decided Monday when a New Jersey federal judge excluded as "pure speculation" the plaintiff's medical expert who testified that the drug caused a patient's liver cancer.

  • November 12, 2025

    Kratom Consumer Drops Suit Over Seltzer's 'Addictive' Effects

    A Washington consumer who claims she became addicted to beverage maker Mitra-9's kratom-based seltzers, powders and shots has agreed to drop her lawsuit weeks after the company called the buyer out for claiming to have bought the products before it was even established.

  • November 12, 2025

    NJ Justices Keep Ozempic Injury Mass Torts Separate

    The New Jersey Supreme Court has decided not to combine two Bergen County Superior Court mass tort cases over weight loss drugs including Ozempic, Wegovy and Mounjaro, keeping them separate based on the type of injury alleged.

  • November 12, 2025

    Purdue Kicks Off Ch. 11 Confirmation With Plan Overview

    Bankrupt OxyContin maker Purdue Pharma began its Chapter 11 confirmation trial Wednesday with an overview of its latest plan and the myriad settlements that underpin the proposal, including a $6.5 billion commitment from the company's owners.

Expert Analysis

  • Keys To Extended Producer Responsibility Compliance

    Author Photo

    As states' extended producer responsibility laws come into effect, reshaping packaging obligations for businesses, regulated entities should ensure they register with a producer responsibility organization, understand state-specific deadlines and obligations, and review packaging to improve recyclability and reduce compliance costs, say attorneys at Baker Donelson.

  • Demystifying Generative AI For The Modern Juror

    Author Photo

    In cases alleging that the training of artificial intelligence tools violated copyright laws, successful outcomes may hinge in part on the litigator's ability to clearly present AI concepts through a persuasive narrative that connects with ordinary jurors, say Liz Babbitt at IMS Legal Strategies and Devon Madon at GlobalLogic.

  • 3rd Circ. Clarifies Ch. 11 3rd-Party Liability Scope Post-Purdue

    Author Photo

    A recent Third Circuit decision that tort claims against the purchaser of a debtor's business belong to the debtor's bankruptcy estate reinvigorates the use of Chapter 11 for the resolution of nondebtor liability in mass tort bankruptcies following last year's U.S. Supreme Court ruling in Purdue Pharma, say attorneys at Sullivan & Cromwell.

  • Series

    Power To The Paralegals: How And Why Training Must Evolve

    Author Photo

    Empowering paralegals through new models of education that emphasize digital fluency, interdisciplinary collaboration and human-centered lawyering could help solve workforce challenges and the justice gap — if firms, educators and policymakers get on board, say Kristine Custodio Suero and Kelli Radnothy.

  • Series

    Playing Softball Makes Me A Better Lawyer

    Author Photo

    My time on the softball field has taught me lessons that also apply to success in legal work — on effective preparation, flexibility, communication and teamwork, says Sarah Abrams at Baleen Specialty.

  • And Now A Word From The Panel: Choosing MDL Venues

    Author Photo

    One of the most interesting yet least predictable facets of the Judicial Panel on Multidistrict Litigation's practice is venue — namely where the panel decides to place a new MDL proceeding — and its choices reflect the tension between neutrality and case-specific factors, says Alan Rothman at Sidley.

  • How New Rule On Illustrative Aids Is Faring In Federal Courts

    Author Photo

    In the 10 months since new standards were codified for illustrative aids in federal trials, courts have already begun to clarify the rule's application in different contexts and the rule's boundaries, say attorneys at Bernstein Litowitz.

  • Analyzing AI's Evolving Role In Class Action Claims Admin

    Author Photo

    Artificial intelligence is becoming a strategic asset in the hands of skilled litigators, reshaping everything from class certification strategy to claims analysis — and now, the nuts and bolts of settlement administration, with synthetic fraud, algorithmic review and ethical tension emerging as central concerns, says Dominique Fite at CPT Group.

  • Vanda Ruling Opens Door For Contesting FDA Drug Denials

    Author Photo

    The D.C. Circuit's recent decision in Vanda Pharmaceuticals v. U.S. Food and Drug Administration creates new opportunities and considerations for drug companies navigating the FDA approval process, establishing that litigation is an option when the FDA refuses to hold a hearing, say attorneys at Polsinelli.

  • Series

    Law School's Missed Lessons: Mastering Time Management

    Author Photo

    Law students typically have weeks or months to prepare for any given deadline, but the unpredictability of practicing in the real world means that lawyers must become time-management pros, ready to adapt to scheduling conflicts and unexpected assignments at any given moment, says David Thomas at Honigman.

  • How Hyperlinks Are Changing E-Discovery Responsibilities

    Author Photo

    A recent e-discovery dispute over hyperlinked data in Hubbard v. Crow shows how courts have increasingly broadened the definition of control to account for cloud-based evidence, and why organizations must rethink preservation practices to avoid spoliation risks, says Bree Murphy at Exterro.

  • State False Claims Acts Can Help Curb Opioid Fund Fraud

    Author Photo

    State versions of the federal False Claims Act can play an important role in policing the misuse of opioid settlement funds, taking a cue from the U.S. Department of Justice’s handling of federal fraud cases involving pandemic relief funds, says Kenneth Levine at Stone & Magnanini.

  • Strategies To Get The Most Out Of A Mock Jury Exercise

    Author Photo

    A Florida federal jury’s recent $329 million verdict against Tesla over a fatal crash demonstrates how jurors’ perceptions of nuanced facts can make or break a case, and why attorneys must maximize the potential of their mock jury exercises to pinpoint the best trial strategy, says Jennifer Catero at Snell & Wilmer.

  • Series

    Writing Musicals Makes Me A Better Lawyer

    Author Photo

    My experiences with writing musicals and practicing law have shown that the building blocks for both endeavors are one and the same, because drama is necessary for the law to exist, says Addison O’Donnell at LOIS Law.

  • What Prop 65 Ruling Means For Cosmetics, Personal Care Biz

    Author Photo

    A California federal court's recent decision on Proposition 65 warnings is good news for companies in the cosmetics and personal care space, as it will relieve businesses of the need to apply such warnings to products containing titanium dioxide and likely stop a wave of pending failure-to-warn litigation, say attorneys at Morgan Lewis.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Product Liability archive.